E-protein-regulated expression of CXCR4 adheres preselection thymocytes to the thymic cortex.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
05 08 2019
Historique:
received: 11 12 2018
revised: 14 02 2019
accepted: 20 05 2019
pubmed: 16 6 2019
medline: 20 6 2020
entrez: 16 6 2019
Statut: ppublish

Résumé

Preselection thymocytes are normally retained in the thymic cortex, but the mechanisms responsible remain incompletely understood. We now report that deletion of genes encoding the E-protein transcription factors E2A and HEB disorders chemokine receptor expression on developing thymocytes to allow escape of preselection TCR

Identifiants

pubmed: 31201207
pii: jem.20182285
doi: 10.1084/jem.20182285
pmc: PMC6683992
doi:

Substances chimiques

Basic Helix-Loop-Helix Transcription Factors 0
CD8 Antigens 0
CXCR4 protein, human 0
Chemokine CXCL12 0
Cxcl12 protein, mouse 0
Receptors, Antigen, T-Cell 0
Receptors, CXCR4 0
Tcf12 protein, mouse 0
Tcf3 protein, mouse 0

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1749-1761

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI102853
Pays : United States

Informations de copyright

© 2019 Kadakia et al.

Références

J Immunol. 1999 May 15;162(10):5981-5
pubmed: 10229836
J Immunol. 1999 Sep 1;163(5):2353-7
pubmed: 10452965
Immunity. 2000 Feb;12(2):121-7
pubmed: 10714678
Nat Med. 2000 May;6(5):543-8
pubmed: 10802710
J Biol Chem. 2001 Nov 2;276(44):40746-54
pubmed: 11522790
Immunity. 2001 Nov;15(5):763-74
pubmed: 11728338
Nat Rev Immunol. 2001 Dec;1(3):193-9
pubmed: 11905828
Int Immunol. 2002 Jun;14(6):535-44
pubmed: 12039905
J Immunol. 2003 Nov 1;171(9):4521-7
pubmed: 14568925
Nature. 2004 Jan 22;427(6972):355-60
pubmed: 14737169
J Exp Med. 2004 Aug 16;200(4):493-505
pubmed: 15302902
J Immunol. 2005 Mar 1;174(5):2485-8
pubmed: 15728452
J Immunol. 2005 Oct 15;175(8):5115-25
pubmed: 16210615
Immunity. 2006 Feb;24(2):165-77
pubmed: 16473829
Nat Rev Immunol. 2006 Feb;6(2):127-35
pubmed: 16491137
Blood. 2007 May 1;109(9):3803-11
pubmed: 17213286
Annu Rev Immunol. 2007;25:649-79
pubmed: 17291187
Nat Rev Immunol. 2007 Jun;7(6):454-65
pubmed: 17525754
J Exp Med. 2007 Aug 6;204(8):1945-57
pubmed: 17646406
J Exp Med. 2007 Oct 29;204(11):2513-20
pubmed: 17908937
Immunity. 2007 Dec;27(6):860-70
pubmed: 18093538
Immunity. 2008 Dec 19;29(6):888-98
pubmed: 19027330
Nat Immunol. 2010 Feb;11(2):162-70
pubmed: 20010845
Nat Immunol. 2010 Mar;11(3):257-64
pubmed: 20118929
J Biol Chem. 2010 Jul 16;285(29):22328-37
pubmed: 20463015
Immunol Rev. 2010 Nov;238(1):93-109
pubmed: 20969587
Immunol Cell Biol. 2011 Feb;89(2):185-96
pubmed: 21135866
Nat Rev Immunol. 2011 Jun 24;11(7):469-77
pubmed: 21701522
J Exp Med. 2012 Nov 19;209(12):2263-76
pubmed: 23109710
Nature. 2013 Mar 14;495(7440):231-5
pubmed: 23434755
J Clin Invest. 2013 May;123(5):2131-42
pubmed: 23585474
Curr Top Dev Biol. 2014;110:153-87
pubmed: 25248476
Nat Immunol. 2016 Dec;17(12):1415-1423
pubmed: 27668801
Sci Rep. 2017 Jul 11;7(1):5068
pubmed: 28698642
Nat Immunol. 2017 Nov;18(11):1218-1227
pubmed: 28945245
Trends Immunol. 2018 Feb;39(2):86-98
pubmed: 29162323
Cell Rep. 2018 Jul 3;24(1):117-129
pubmed: 29972774
Nature. 1996 Aug 29;382(6594):829-33
pubmed: 8752280
J Exp Med. 1998 Jul 6;188(1):181-91
pubmed: 9653094
Int Immunol. 1998 Aug;10(8):1049-56
pubmed: 9723690
J Immunol. 1998 Nov 1;161(9):4688-94
pubmed: 9794398

Auteurs

Tejas Kadakia (T)

Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Xuguang Tai (X)

Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Michael Kruhlak (M)

Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Jan Wisniewski (J)

Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Il-Young Hwang (IY)

B Cell Molecular Immunology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Sumedha Roy (S)

Department of Immunology, Duke University Medical Center, Durham, NC.

Terry I Guinter (TI)

Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Amala Alag (A)

Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

John H Kehrl (JH)

B Cell Molecular Immunology Section, Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Yuan Zhuang (Y)

Department of Immunology, Duke University Medical Center, Durham, NC.

Alfred Singer (A)

Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD singera@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH